Novel imantib resistance mechanisms in chronic myloid leukemia
In my research, I found that the compensatory activation of PI3K/AKT/mTor signaling pathway contributes early imatinib resistance in LAMA cell models. We also found that the auto/paracrine of GM-CSF by imatinib resistant leukemic cells confers to potent imatinib and nilotinib resistance. These findi...
Сохранить в:
Главный автор: | |
---|---|
Другие авторы: | |
Формат: | Dissertation |
Язык: | английский |
Опубликовано: |
Philipps-Universität Marburg
2007
|
Предметы: | |
Online-ссылка: | PDF-полный текст |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
No citations were found for this record.